论文部分内容阅读
淋巴瘤是一组起源于淋巴结和其他淋巴组织的恶性肿瘤,可分为霍奇金淋巴瘤和非霍杰金淋巴瘤(NHL),其中NHL占绝大多数。全世界每年有约21万人因NHL而死亡〔1〕。在美国,NHL年发病率为20/100 000,已达到其平台期〔2〕。根据2009年的数据,中国淋巴瘤发病率为6.8/100 000,在恶性肿瘤中排名第8,每年有4.87万人因淋巴瘤而死
Lymphoma is a group of malignant tumors that originate in lymph nodes and other lymphoid tissues and can be divided into Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (NHL), of which NHL accounts for the majority. About 210,000 people die of NHL each year worldwide [1]. In the United States, the annual incidence of NHL is 20/100 000, reaching its plateau (2). According to 2009 data, the incidence of lymphoma in China is 6.8 / 100 000, ranking the 8th among malignant tumors, with 48.77 million people died each year due to lymphoma